// Post a message

Replying to:

Reliable Cancer Therapies-MGHI parnership

RCT (Reliable Cancer Therapies) have agreed to help financing the Fluvabrex Phase I trial that will investigate the tolerance and preliminary activity of fluvastatine and celecoxib in refractory low grade glioma. Recruitment shall start Q1-Q2 (...)

pre-moderation

This forum is moderated beforehand: your contribution will only appear after being validated by a site administrator.

Any message or comment?
  • (To create paragraphs, you simply leave blank lines.)

Who are you? (optional)